SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Enzon Pharmaceuticals (Piscataway, New Jersey) Announces Data From Phase I Study of PEG-SN38 in Pediatric Neuroblastoma and Other Solid Tumors Presented at 2012 Advances in Neuroblastoma Research Conference